Skip to content

Why Most Market Landscape Studies Get Commissioned After the Decision Is Already Made

A. Kovacs A. Kovacs
/ / 4 min read

Ask any tech transfer director how they decide whether a technology is worth pursuing, and most will mention a market landscape study at some point. A consultant gets hired, a report gets produced, slides get made for the committee. Sounds rigorous.

A panoramic view of Stuttgart's industrial district with buildings and greenery under a clear blue sky. Photo by Andreas Maier on Pexels.

Here's the problem: by the time most of these studies get commissioned, the committee has already decided what they want to hear. The study isn't shaping the decision. It's dressing up a decision that happened in a hallway conversation three months earlier.

I've watched this pattern play out dozens of times. A faculty inventor has a champion on the licensing team. That champion wants the technology to move forward, often for good reasons: the science is strong, the inventor is engaged, there's a provisional patent already filed. So the champion pushes for a market study, but the request to the consultant is subtly loaded. "Can you validate the opportunity in oncology diagnostics?" is a different question than "Is there a viable market here at all?" Consultants, who want repeat business, tend to answer the question they're asked.

The sequencing problem

Market studies work best when they happen before anyone has emotional or political investment in the outcome. In practice, they get ordered after a provisional patent is filed, after a faculty member has started telling colleagues about their startup, and after internal momentum has built. At that point, a market study that says "this is a crowded space with thin margins" doesn't kill the project. It just gets filed away, unread, while the project proceeds on inertia.

The timing matters more than the methodology. A mediocre market study done at the invisible disclosure stage, before anyone has picked a lane, is more valuable than an expensive, well-researched one done after the die is cast.

graph TD
    A[Invention Disclosure] --> B{Market Study Timing?}
    B -->|Early, before commitment| C[Shapes patent strategy and go/no-go]
    B -->|Late, after momentum builds| D[Confirms existing plan regardless of findings]
    D --> E[Wasted spend, false confidence]
    C --> F[Resources directed to real opportunities]

What a useful study actually looks like

A market landscape study that earns its cost does three things most commissioned reports skip entirely. First, it names the specific buyer, not the industry. "The medical device market" tells you nothing; "hospital procurement committees evaluating sub-$50K capital equipment with a 90-day budget cycle" tells you something you can act on. Second, it identifies who else has tried this approach and failed, and why, rather than just listing competitors who are currently active. Failed attempts carry more diagnostic information than successful ones. Third, it gives a number for total addressable spend that someone could actually defend in a room full of skeptics, with the assumptions shown, not hidden in an appendix.

Most reports I've reviewed do none of these. They list competitors, cite a market-size figure pulled from a syndicated research firm (often inflated, often irrelevant to the specific sub-segment), and conclude with some version of "significant opportunity exists." That sentence should be a warning sign, not a conclusion.

Who should actually read these

The real audience for a market landscape study isn't the licensing committee looking for cover to approve a patent filing they already wanted to approve. It's the faculty inventor, who usually has never seen a customer segmentation analysis and genuinely doesn't know whether their technology solves a problem anyone will pay to fix. Put the study in front of them early, before they've told their department chair they're starting a company, and you get actual behavior change: narrower claims, different partners, sometimes a decision to walk away entirely.

That's an uncomfortable use of the tool for offices that see market studies as a procedural checkbox. It requires commissioning the work when the stakes feel lowest and the willingness to actually be told no. Offices that do this well tend to kill more projects earlier and spend less money overall on dead licenses. Offices that do it late just get expensive paperwork confirming what the hallway conversation already decided.

Get Commercializing Science in your inbox

New posts delivered directly. No spam.

No spam. Unsubscribe anytime.

Related Reading